中国医药健康产业股份有限公司第九届董事会第33次会议决议公告

Meeting Details - The 33rd meeting of the 9th Board of Directors of China National Pharmaceutical Group Co., Ltd. was held on November 24, 2025, in a combination of in-person and communication methods, chaired by Chairman and General Manager Yang Guang [2] - The meeting notification was sent to all directors on November 19, 2025, via email, SMS, phone, or fax [3] - A total of 8 directors were supposed to attend the meeting, and all 8 directors actually participated [4] - The meeting was conducted in accordance with the relevant provisions of the Company Law and the Articles of Association, making the resolutions valid [5] Resolutions Passed - The meeting approved the proposal to revise the "Internal Audit Work Regulations" [6] - The voting results for this proposal were unanimous, with 8 votes in favor, 0 against, and 0 abstentions [8] - The meeting also approved the proposal to establish the "Board Meeting Proposal Management Measures" [9] - The voting results for this proposal were also unanimous, with 8 votes in favor, 0 against, and 0 abstentions [11]